BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Nuclear receptor subfamily 2 group F member 1 (NR2F1; COUP-TFI)

February 12, 2015 8:00 AM UTC

Studies in cell culture, mice and patient samples suggest activating NR2F1 could help prevent cancer metastasis by inducing tumor dormancy. In patient-derived disseminated prostate tumor cells and a h...